Bain Capital acquires specialty chemicals firm Porus Labs
Porus Labs makes speciality polymers, electronic chemicals, and agrochemicals
Porus Labs makes speciality polymers, electronic chemicals, and agrochemicals
Company has invested around €120 million in the new facility at Shandong, China
As well as expanding capacity, the project includes substantial capital expenditures for research and innovation
The plant's green ammonia production will be purchased and sold by Trammo to contribute to the decarbonization of northern European industry.
Company has nominated Geert Olbrechts as its Chief Technology Officer (CTO) and member of the Management Board, effective on August 1st
The opening of this 59,000-square-foot facility upholds Aspen Aerogels' commitment to supporting the growth of the electrification movement
Rinchem is expanding its network of chemical storage facilities to meet the growing demands of the industry
India’s battery material industry, which was valued at US $1.66 billion in 2020 and is projected to reach US $4.85 billion by 2027
This transaction gives Elkem improved access to central and eastern European markets
This acquisition reinforces Technip Energies’ digital portfolio and fits with its energy transition ambition
Company is developing a strong and diverse pipeline of effective biocontrol products with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate
Production is forecast to begin in 2026, with 40,000 tonnes a year output
The acquisition of JBFPL offers GAIL an opportunity to add PTA to GAIL's existing petrochemical portfolio
The doubling of SAF production at Grandpuits, bringing the site’s annual production capacity to 285,000 tons
Matt Abbott as promoted to Chief Enterprise Transformation Officer
Digitalization may have several positives, but it serves as a catalyst for most companies to help create an agile and sustainable environment
BAL is all set to launch this product in July with the brand name Tricolor
New facility will strengthen the security of supply for global pharmaceutical and biotech customers and will support the continued development and production of lifesaving clinical and commercial-scale therapeutics for patients worldwide.
Under the terms of the VPPA, IGNIS will produce renewable energy equal to Lonza’s electricity needs across Switzerland and the European Union.
Construction will begin this year with the new capacity anticipated by 2025
Subscribe To Our Newsletter & Stay Updated